Embera is a specialty pharma company developing a novel treatment for the $1.9B smoking cessation market and cocaine dependence (no approved treatments today).
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free